SOLICITATION NOTICE
66 -- Acquisition of a NextSeq 500 Sequencing System
- Notice Date
- 8/9/2016
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N02RC62587-76
- Archive Date
- 8/20/2016
- Point of Contact
- Catherine Muir, Phone: (240) 276-5434
- E-Mail Address
-
muirca@mail.nih.gov
(muirca@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E144, Bethesda, MD 20892, UNITED STATES Description: National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Biochemistry and Molecular Biology (LBMB), plans to procure on a sole source basis a NextSeq 500 Sequencing System that is manufactured by Illumina, Inc., 5200 Illumina Way, San Diego, CA 92121-1975. The response close date of this notice for this requirement is in accordance with FAR 5.203(a)(1). This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1), and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 334516 and the business size standard is 1,000 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. The period of performance: delivery is expected within 90 days of award. It has been determined there are no opportunities to acquire green products or services for this procurement. The Laboratory of Biochemistry and Molecular Biology (LBMB) carries out basic research into the mechanisms underlying cell growth, division, differentiation and homeostasis with a focus on the biology of chromosomes and the cell nucleus. LBMB fosters an interdisciplinary approach in which the methods of biophysics, biochemistry, genetics and cell biology are used in an interactive and collaborative research environment to solve problems of fundamental importance. The LBMB investigates the fundamental mechanisms of chromosome biology. Its laboratories study how chromosomes are accurately segregated, how they are organized, how compacted domains are formed, how gene expression patterns are regulated, and how structure contributes to the maintenance of genome stability. The lab takes a multidisciplinary approach, leveraging the power of yeast genetics, biochemistry, and cutting edge cell biological techniques, in the investigation of the biology surrounding chromosomes and the many mechanisms that ensure their stable maintenance. As part of the LBMB's research approach, it performs a variety of genome-wide analysis techniques such as ChIP-Seq, RNA-Seq, and the 3D genome architecture analysis method, Hi-C. These approaches require access to the latest massively parallel sequencing technology for genome-wide analysis and functional genomic studies. Laboratories within LBMB investigate many aspects of chromosome biology, including heterochromatin formation, chromosome segregation, regulation of genome stability, and maintenance of telomeres. Particularly relevant to this acquisition is its focus on genome-wide sequencing analyses as part of its routine research. LBMB labs have greatly expanded its use of next generation sequencing (NGS) to perform a variety of genome-wide analysis techniques, such as ChIP-Seq, RNA-Seq, and the powerful 3D genome architecture analysis method, Hi-C. The increased requirements within the branch have led to a need for frequent access to this technology. The purchase of this latest NGS technology is of critical importance and will greatly facilitate its research progress. The Contractor shall provide the following: TECHNICAL REQUIREMENTS: Features that are required for one (1) integrated automated NGS high-throughput system include: * capable of accommodating genome-wide analyses of genomes ranging from yeast (13Mb) to human (>3Gb) * capable of microarray scanning * load-and-go operation (max. thirty (30) hours for a paired 150-cycle read) * contain scalability (20-120 Gb) of high output * fully automated user interface, push-button operation desktop system including: > an embedded touchscreen monitor > an on-instrument computer and the necessary controller software (compatible with Windows 7) * compatibility with a full range of library preparation kits * provide access to genomic analysis tools through BaseSpace application * Installation and training * twelve (12) months warranty (including parts and labor) DELIVERY: Contractor shall provide standard delivery of the instrument within 90 days after the award to: NIH/NCI Bethesda, Maryland 20892. Upon delivery, contractor must notify the NCI Contracting Officer's Representative, shown on the award, to schedule the delivery date and time. INSTALLATION: Contractor shall install the specified equipment and have ready to use within seven (7) days after delivery and acceptance. Payment shall be made in arrears after delivery, installation, and upon Government acceptance of the specified equipment, and submission of an invoice to the address shown in the award pursuant to the invoicing instructions in the award. Illumina, Inc. is the only known manufacturer of a fully integrated and automated next generation system that applies parallel sequencing technology to performing genome wide analyses and functional genome studies. Specifically, the proposed equipment is capable of accommodating genome-wide analyses of genomes ranging from yeast (13Mb) to human (>3Gb) that are studied by the lab groups in the LBMB that meets all of the stated technical and scientific requirements required by the LBMB. This notice is not a request for competitive quotation. However, if any interested party, especially small businesses, believes it can meet the above requirement, it may submit a capability statement, proposal, or quotation, which shall be considered by the agency. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow the NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 2:00PM EDT, on August 19, 2016. All responses and questions must be in writing and faxed (240) 276-5401 or emailed to Catherine Muir, Contracting Officer via electronic mail at muirca@mail.nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, Contractors must be registered and have valid, current Entity Record, including current Representations and Certifications, in the System for Award Management (SAM) through SAM.gov. Reference: N02RC62587-76 on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02RC62587-76/listing.html)
- Record
- SN04216027-W 20160811/160809235747-c46ec9dab9803049f8b98b16aa2dce39 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |